Dunn Edmund — SEC Form 4 filings
SEC reporting owner CIK 1989401. 7 Form 4 filings on record with FilingPulse; latest filed 2026-03-05.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-06-05 to 2026-03-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 6 filings — 31,757 shares, $503,361 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: sale of 25,164 shares @ $18.10 ($455,506) in Monte Rosa Therapeutics, Inc., filed 2026-03-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc. (GLUE) | Principal Accounting Officer | 7 | — | 7 legs · 31,757 sh · $503,361 | 6 |
Form 4 filings — Dunn Edmund
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-05 | 4 | Monte Rosa Therapeutics, Inc. (GLUE) | Sale (S): 139 @ $17.96 | EDGAR |
| 2026-03-02 | 4 | Monte Rosa Therapeutics, Inc. (GLUE) | Option exercise (M): 25,164 @ $13.41 · Sale (S): 25,164 @ $18.10 · Option exercise (M): 536 @ $13.41 · Sale (S): 536 @ $17.50 · Option exercise (M): 25,164 (derivative) @ $0 · Option exercise (M): 536 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Monte Rosa Therapeutics, Inc. (GLUE) | Sale (S): 1,039 @ $15.17 | EDGAR |
| 2025-06-04 | 4 | Monte Rosa Therapeutics, Inc. (GLUE) | Sale (S): 2,062 @ $4.45 | EDGAR |
| 2025-01-06 | 4 | Monte Rosa Therapeutics, Inc. (GLUE) | Grant/award (A): 11,850 · Grant/award (A): 53,400 (derivative) @ $0 | EDGAR |
| 2024-07-09 | 4 | Monte Rosa Therapeutics, Inc. (GLUE) | Sale (S): 1,610 @ $3.83 | EDGAR |
| 2024-06-05 | 4 | Monte Rosa Therapeutics, Inc. (GLUE) | Sale (S): 1,207 @ $4.04 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1989401 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →